AIMD - Latest News

Ainos, Inc. (AIMD), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $7.1M. Beta to the broader market is 2.48.

The article list below shows the most recent AIMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AIMD Headlines

Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment

accessnewswire.com - Sep 30, 2026

Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business Days HOUSTON, TX / ACCESS Newswire / Septem

Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract

accessnewswire.com - Sep 29, 2026

Preparations underway for a larger-scale second-phase deployment specified in the existing MOU, building on first-phase deployment experience Advanced

Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence

accessnewswire.com - Sep 28, 2026

Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Pa

Ainos, Inc. (NASDAQ:AIMD) Shares Shorted: Short Interest Up 172.6% in September

defenseworld.net - Sep 27, 2026

Ainos, Inc. (NASDAQ: AIMD - Get Free Report) was the recipient of a large growth in short interest in September.

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

accessnewswire.com - Sep 24, 2026

Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two

How News Affects AIMD Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AIMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AIMD news questions

What is the latest AIMD news headline?

The most recent AIMD headline (Sep 30, 2026) is "Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the AIMD news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What AIMD news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual AIMD options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.